Geeta Vemuri

Managing Partner and Founder at Agent Capital

Geeta Vemuri is the Founder and Managing Partner of Agent Capital (agentcapital.com), where she leads the firm’s healthcare-focused venture investments. A seasoned biotechnology and healthcare investor, she has served as a board member or observer for companies including True North Therapeutics (acquired by Bioverativ), SyntImmune (acquired by Alexion), Covagen (acquired by Janssen), Metagenomi, and Pyxis Oncology. Previously, she led corporate venture groups at Baxter and Baxalta. Geeta holds a Ph.D. in Biochemistry from the Indian Institute of Science and an MBA in Finance from The Wharton School. LinkedIn: https://www.linkedin.com/in/geeta-vemuri-24849b105.